Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®

Vun, Simon; Rashid, Syma; Blest, Nadia; Spark, J.I.

doi:10.1177/0268355514553693

Cited by 43 publications

(34 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A total of 28% of patients presented with small hematomas, 17% had local skin hardening, and 18% felt discomfort for more than a week after the procedure. High effectiveness of this method over follow-up periods ranging from 6 to 24 months has been confirmed in several other studies [15][16][17][18][19][20].…”

Section: Discussionmentioning

confidence: 60%

Application of endovenous mechanochemical ablation (MOCA) with Flebogrif™ to treat varicose veins of the lower extremities: a single center experience over 3 months of observation

Zubilewicz

Terlecki

et al. 2017

Acta Angiologica

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 60%

Application of endovenous mechanochemical ablation (MOCA) with Flebogrif™ to treat varicose veins of the lower extremities: a single center experience over 3 months of observation

Zubilewicz

Terlecki

et al. 2017

Acta Angiologica

View full text Add to dashboard Cite

show abstract

“…In short-and mid-term time after the procedure, the rate of clinical complications is also very low for NTNT [51], even the intra-and postprocedural pain seems to be lower for MOCA and CA than for EVTA. Other minor and major complication rates, time to return to work, and normal activity do not differ significantly [36,[52][53][54][55][56].…”

Section: Results Of the Endovenous Ablation Techniques -Clinical Outcomementioning

confidence: 85%

Are non-thermal, non-tumescent techniques more recommended? Endovenous treatment of saphenous veins reflux – methods and results overview and discussion

Zieliński¹,

Świercz²

2018

View full text Add to dashboard Cite

Chronic venous disease is one of the biggest health problems of today's word. The consequences of the progression of venous disorders can lead to severe acute complications like superficial venous thrombosis, deep vein thrombosis, and pulmonary embolism, as well as chronic venous ulcers. The costs of the treatment of these conditions are still growing. The development of minimally invasive techniques has led to huge progress in the treatment of chronic venous disease. There are many modalities in the phlebological armamentarium, which can be chosen to eliminate axial reflux that is responsible for the progression of disease in the majority of cases. Various groups of techniques can be used: thermal and tumescent procedures, non-thermal tumescent options, or non-thermal non-tumescent treatment. In recent years special interest has been directed towards non-thermal, non-tumescent modalities, following suggestions that these procedures would create the same effects as thermal-tumescent ones, but are less invasive and give the patient a better outcome and quality of life. The review of recently published studies did not confirm this theory in general; however, some superiority of these options is present. Thus, further investigations and trials on this issue are highly recommended. Currently there is not enough strong evidence to promote non-thermal, non-tumescent techniques over other endovenous modalities.

show abstract

“…It should be emphasised that our team began the research on injuring the endothelium in addition to chemical ablation before the invention of the ClariVein system was released. Considering the good results of the ClariVein, our concept of mechanochemical ablation seems to be correct [5][6][7]. The mechanism of action of the Phlebogriffe has a solid pathophysiological basis [8][9][10].…”

Section: Discussionmentioning

confidence: 99%

Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study

Ciostek¹,

Kowalski²,

Woźniak³

et al. 2015

View full text Add to dashboard Cite

Objectives: The aim of this study was to evaluate the feasibility, safety and early results of mechanochemical ablation of incompetent varicose veins using a special catheter: the Phlebogriffe. Material and methods:The design of this catheter is based on a typical diagnostic catheter. Into this catheter a metal shank, attached to which are 5 thin, curved, springy wires with sharpened ends, is introduced. After being pushed out of the catheter, these wires deploy into a cat's claw pattern. When the whole device -the catheter and shank with open claws -is being pulled out, sclerosing foam is administered. In this pilot study, which was performed in the years 2011-2013, we evaluated 40 patients with varicose veins. Efficacy of the procedure, defined as closure of the treated vein, and clinical result evaluated using the Venous Clinical Severity Score (VCSS) were assessed after 1, 3, 6 and 12 months. Results: Efficacy of the procedure after 1, 3, 6 and 12 months was 97.4%, 94.9%, 89.7% and 89.7%, respectively. Statistical analysis of the VCSS before the procedure and after 12 months revealed statistically significant improvements regarding pain, presence of varicose veins, oedema, number and size of active ulcers, their duration, size of active ulcers and the use of compression therapy. The average improvement in VCSS scores was 3.56 points. Conclusions:The Phlebogriffe is a device that offers new opportunities for safe and efficient treatment of varicose veins associated with incompetence of saphenous veins.

show abstract

Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®

Cited by 43 publications

References 19 publications

Application of endovenous mechanochemical ablation (MOCA) with Flebogrif™ to treat varicose veins of the lower extremities: a single center experience over 3 months of observation

Application of endovenous mechanochemical ablation (MOCA) with Flebogrif™ to treat varicose veins of the lower extremities: a single center experience over 3 months of observation

Are non-thermal, non-tumescent techniques more recommended? Endovenous treatment of saphenous veins reflux – methods and results overview and discussion

Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study

Contact Info

Product

Resources

About